DrugPatentWatch Database Preview
Watson Labs Company Profile
What is the competitive landscape for WATSON LABS, and what generic and branded alternatives to WATSON LABS drugs are available?
WATSON LABS has one thousand and thirty-three approved drugs.
There are twenty tentative approvals on WATSON LABS drugs.
Summary for Watson Labs
| US Patents: | 0 |
| Tradenames: | 399 |
| Ingredients: | 376 |
| NDAs: | 1033 |
Drugs and US Patents for Watson Labs
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Watson Labs | TRIAMCINOLONE | triamcinolone | TABLET;ORAL | 084270-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Start Trial | Start Trial | |||||
| Watson Labs | LORAZEPAM | lorazepam | TABLET;ORAL | 071117-001 | Jul 24, 1986 | DISCN | No | No | Start Trial | Start Trial | |||||
| Watson Labs | PREDNISONE | prednisone | TABLET;ORAL | 085161-001 | Approved Prior to Jan 1, 1982 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Watson Labs | PIROXICAM | piroxicam | CAPSULE;ORAL | 074287-001 | May 16, 1996 | DISCN | No | No | Start Trial | Start Trial | |||||
| Watson Labs | AMITRIPTYLINE HYDROCHLORIDE | amitriptyline hydrochloride | TABLET;ORAL | 088621-001 | Mar 2, 1984 | DISCN | No | No | Start Trial | Start Trial | |||||
| Watson Labs | CARISOPRODOL | carisoprodol | TABLET;ORAL | 085433-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Start Trial | Start Trial | |||||
| Watson Labs | NITROFURANTOIN MACROCRYSTALLINE | nitrofurantoin, macrocrystalline | CAPSULE;ORAL | 070249-001 | Jun 24, 1988 | DISCN | No | No | Start Trial | Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
